Retrobulbar Optic Neuritis Induced by Anti-TNF-a agent, Infliximab, and Recurrence Following Rechallenge

Update Item Information
Identifier 20030210_nanos_posters_053
Title Retrobulbar Optic Neuritis Induced by Anti-TNF-a agent, Infliximab, and Recurrence Following Rechallenge
Creator Sonal B. Dave, MD; Steve Goldin MD; Michael Wall, MD; Andrew Lee, MD; Randy Kardon, MD, PhD
Affiliation Iowa City, IA
Subject Optic Neuritis; Infliximab; Anti-TNF-Alpha
Description Infliximab is an anti-TNF-a medication approved for treatment of rheumatoid arthritis and Crohn's disease and is being used with increasing frequency as an immune modulating agent. It has also been found to exacerbate demyelination in patients with multiple sclerosis enrolled in a treatment trial.
Date 2003-02-11
Language eng
Format application/pdf
Type Text
Source 2003 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of NANOS 2003: Poster Presentations
Collection Neuro-Ophthalmology Virtual Education Library: NANOS Annual Meeting Collection: https://novel.utah.edu/collection/nanos-annual-meeting-collection/
Publisher North American Neuro-Ophthalmology Society
Holding Institution Spencer S. Eccles Health Sciences Library, University of Utah
Rights Management Copyright 2010. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s69340pt
Setname ehsl_novel_nam
ID 181567
Reference URL https://collections.lib.utah.edu/ark:/87278/s69340pt
Back to Search Results